Inspire Investing 13F: Adds $2.6M to Globus Medical (GMED) Stake

Inspire Investing increased its stake in Globus Medical, Inc. GMED by 34,234 shares during the quarter, bringing its total investment to 41,600 shares. The fund disclosed the move in a Form 13F filed with the SEC on October 22, 2026. The reported value of the holding reached about $3.11 million at the time of the filing.

GMED Globus Medical, Inc.

$81.41 ▼ -6.75% year to date

1M 3M YTD

Daily close · Oct 23, 2026

What Changed in Inspire Investing's Globus Medical Position

Inspire Investing lifted its position by a 464.8% margin compared to its previous holding of 7,366 shares. The sizable addition brings the fund's investment in the medical device maker to a total value of $3,115,840.

Other Institutional Activity in Globus Medical

Other institutional investors also adjusted their positions in the healthcare company around the same period. GW&K Investment Management reduced its holdings by 21,622 shares, ending with 1,494,723 shares valued at about $118.09 million. Moran Wealth Management initiated a new position by purchasing 38,439 shares worth about $2.87 million. Jupiter Topco LLC grew its stake by 4,100,212 shares, a 100.0% increase, ending with 8,200,423 shares valued at $667.59 million. Kayne Anderson Rudnick Investment Management LLC also doubled its holdings, adding 2,139,865 shares for a 100.0% increase to finish with 4,279,730 shares worth about $348.41 million. Sculptor Capital LP trimmed its stake by 58,104 shares, a 1.9% decrease, leaving it with 3,000,000 shares valued at approximately $244.23 million.

Globus Medical, Inc. Stock Up 3.3%

Globus Medical, Inc. shares closed at $81.66 on October 22, 2026. The stock recently traded around $81.28 as of October 24, 2026, putting it down about 0.5% since the filing date. The company holds a market capitalization of roughly $10.96 billion.

Recent Earnings

Globus Medical generated $3.14 billion in trailing twelve-month revenue alongside earnings of $3.90 per share. The company reported a net profit margin of 17.0% and a return on equity of 11.8%. Its next quarterly earnings release is scheduled for November 5, 2026.

Insider Buying and Selling at Globus Medical, Inc.

Company insiders executed several share sales in the months leading up to the filing. General Counsel Kelly Grace Huller sold 20,000 shares on February 25, 2026, at $94.50 for a total of $1.89 million. Director David D. Davidar disposed of 25,000 shares on June 5, 2026, at $80.76 worth about $2.01 million. Director Stephen T. Zarrilli parted with 25,000 shares on August 18, 2026, at $87.04 totaling $2.17 million. Director James R. Tobin sold 30,000 shares on September 15, 2026, at $74.58 for roughly $2.23 million.

Analysts Set New Price Targets

Wall Street firms continue to update their views on the medical device company. On July 13, 2026, RBC Capital maintained an Outperform rating while lowering its target from $120.00 to $115.00. Truist Securities maintained a Buy rating on July 16, 2026, while trimming its price target from $115.00 to $100.00. UBS initiated coverage on July 28, 2026, with a Neutral rating and an 82.00 price target. Wells Fargo maintained an Overweight rating on August 7, 2026, adjusting its target from $103.00 to $99.00. Later, on October 1, 2026, RBC Capital maintained an Outperform rating while lowering its target further to $85.00. Overall, the stock carries a consensus buy recommendation from 13 analysts, with a mean price target of $100.92.

About Globus Medical

Globus Medical, Inc. designs, develops, and sells healthcare products and surgical solutions aimed at treating patients suffering from musculoskeletal disorders. Operating globally, the Audubon, Pennsylvania-based firm provides spinal and orthopedic implants that serve hospitals, surgery centers, and specialized physicians.

Bottom Line

Investors are keeping an eye on Globus Medical as the company approaches its next earnings announcement on November 5, 2026. Institutional additions like Inspire Investing's larger stake highlight ongoing portfolio adjustments in the healthcare sector.